v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 76,905 $ 127,044
Depreciation and amortization 312,663 294,874
Other operating activities and non-cash items 1,312 17,966
Changes in assets and liabilities (108,268) (52,816)
Net cash provided by operating activities 282,612 387,068
Cash flows from investing activities:    
Payments for property, plant and equipment (226,086) (262,543)
Proceeds from sale of property, plant and equipment 4,762 4,813
Proceeds from foreign exchange forward contracts 41,920 5,088
Payments for foreign exchange forward contracts (28,967) (43,091)
Payments for short-term investments (331,393) (279,526)
Proceeds from sale of short-term investments 76,021 30,914
Proceeds from maturities of short-term investments 256,266 263,932
Other investing activities 1,680 5,354
Net cash used in investing activities (205,797) (275,059)
Cash flows from financing activities:    
Proceeds from short-term debt 0 5,012
Payments of short-term debt 0 (8,055)
Proceeds from long-term debt 500,000 58,727
Payments of long-term debt (112,163) (116,921)
Payments of finance lease obligations (30,627) (38,678)
Payments of dividends (40,860) (38,778)
Other financing activities (8,130) 216
Net cash provided by (used in) financing activities 308,220 (138,477)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash 8,792 (13,724)
Net increase (decrease) in cash, cash equivalents and restricted cash 393,827 (40,192)
Cash, cash equivalents and restricted cash, beginning of period 1,134,312 1,120,617
Cash, cash equivalents and restricted cash, end of period 1,528,139 1,080,425
Non-cash investing and financing activities:    
Property, plant and equipment included in capital expenditures payable 383,603 255,244
Right of use assets acquired through operating lease liabilities 982 9,373
Right of use assets acquired through finance lease liabilities 14,009 68,195
Grants and incentive receivables for qualified capital expenditures $ 5,454 $ 0